Logo image of INSP

INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Price, Forecast & Analysis

USA - NYSE:INSP - US4577301090 - Common Stock

81.79 USD
-2.02 (-2.41%)
Last: 11/7/2025, 8:04:00 PM
81.79 USD
0 (0%)
After Hours: 11/7/2025, 8:04:00 PM

INSP Key Statistics, Chart & Performance

Key Statistics
Market Cap2.42B
Revenue(TTM)802.80M
Net Income(TTM)53.12M
Shares29.57M
Float26.85M
52 Week High216.01
52 Week Low70.77
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)2.04
PE40.09
Fwd PE50.76
Earnings (Next)02-09 2026-02-09/amc
IPO2018-05-03
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


INSP short term performance overview.The bars show the price performance of INSP in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20 -30 -40

INSP long term performance overview.The bars show the price performance of INSP in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of INSP is 81.79 USD. In the past month the price increased by 8.81%. In the past year, price decreased by -58.4%.

INSPIRE MEDICAL SYSTEMS INC / INSP Daily stock chart

INSP Latest News, Press Relases and Analysis

INSP Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES25.32219.92B
ISRG INTUITIVE SURGICAL INC65.04200.75B
BSX BOSTON SCIENTIFIC CORP33.91148.20B
SYK STRYKER CORP27.03136.11B
IDXX IDEXX LABORATORIES INC56.1856.68B
BDX BECTON DICKINSON AND CO12.3350.97B
EW EDWARDS LIFESCIENCES CORP32.4548.96B
RMD RESMED INC25.436.70B
GEHC GE HEALTHCARE TECHNOLOGY15.9233.35B
PODD INSULET CORP69.9822.51B
DXCM DEXCOM INC29.5721.57B
ZBH ZIMMER BIOMET HOLDINGS INC10.9417.53B

About INSP

Company Profile

INSP logo image Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,246 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.

Company Info

INSPIRE MEDICAL SYSTEMS INC

5500 Wayzata Blvd Ste 1600

Golden Valley MINNESOTA 55416 US

CEO: TimothyP. Herbert

Employees: 1246

INSP Company Website

INSP Investor Relations

Phone: 17639575037

INSPIRE MEDICAL SYSTEMS INC / INSP FAQ

Can you describe the business of INSPIRE MEDICAL SYSTEMS INC?

Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,246 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.


What is the stock price of INSPIRE MEDICAL SYSTEMS INC today?

The current stock price of INSP is 81.79 USD. The price decreased by -2.41% in the last trading session.


What is the dividend status of INSPIRE MEDICAL SYSTEMS INC?

INSP does not pay a dividend.


What is the ChartMill rating of INSPIRE MEDICAL SYSTEMS INC stock?

INSP has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


When is the next dividend date for INSPIRE MEDICAL SYSTEMS INC (INSP)?

The next ex-dividend date for INSPIRE MEDICAL SYSTEMS INC (INSP) is November 7, 2022.


Would investing in INSPIRE MEDICAL SYSTEMS INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on INSP.


Can you provide the number of employees for INSPIRE MEDICAL SYSTEMS INC?

INSPIRE MEDICAL SYSTEMS INC (INSP) currently has 1246 employees.


INSP Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to INSP. When comparing the yearly performance of all stocks, INSP is a bad performer in the overall market: 89.78% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

INSP Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to INSP. INSP has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INSP Financial Highlights

Over the last trailing twelve months INSP reported a non-GAAP Earnings per Share(EPS) of 2.04. The EPS increased by 90.65% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.17%
ROA 6.62%
ROE 7.84%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-43.33%
Sales Q2Q%10.49%
EPS 1Y (TTM)90.65%
Revenue 1Y (TTM)28.49%

INSP Forecast & Estimates

26 analysts have analysed INSP and the average price target is 127.13 USD. This implies a price increase of 55.43% is expected in the next year compared to the current price of 81.79.

For the next year, analysts expect an EPS growth of -70.2% and a revenue growth 13.03% for INSP


Analysts
Analysts73.85
Price Target127.13 (55.43%)
EPS Next Y-70.2%
Revenue Next Year13.03%

INSP Ownership

Ownership
Inst Owners109.56%
Ins Owners0.82%
Short Float %10.54%
Short Ratio2.84